Aurora Cannabis (ACB) Competitors $5.89 +0.03 (+0.51%) Closing price 04:00 PM EasternExtended Trading$5.90 +0.02 (+0.25%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends ACB vs. ARDX, INDV, NRIX, VIR, SNDX, ARVN, ANIP, DAWN, ADPT, and RCUSShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Ardelyx (ARDX), Indivior (INDV), Nurix Therapeutics (NRIX), Vir Biotechnology (VIR), Syndax Pharmaceuticals (SNDX), Arvinas (ARVN), ANI Pharmaceuticals (ANIP), Day One Biopharmaceuticals (DAWN), Adaptive Biotechnologies (ADPT), and Arcus Biosciences (RCUS). These companies are all part of the "pharmaceutical products" industry. Aurora Cannabis vs. Ardelyx Indivior Nurix Therapeutics Vir Biotechnology Syndax Pharmaceuticals Arvinas ANI Pharmaceuticals Day One Biopharmaceuticals Adaptive Biotechnologies Arcus Biosciences Ardelyx (NASDAQ:ARDX) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, community ranking, profitability, dividends, analyst recommendations, institutional ownership and media sentiment. Does the MarketBeat Community believe in ARDX or ACB? Ardelyx received 149 more outperform votes than Aurora Cannabis when rated by MarketBeat users. Likewise, 67.38% of users gave Ardelyx an outperform vote while only 59.63% of users gave Aurora Cannabis an outperform vote. CompanyUnderperformOutperformArdelyxOutperform Votes53367.38% Underperform Votes25832.62% Aurora CannabisOutperform Votes38459.63% Underperform Votes26040.37% Does the media refer more to ARDX or ACB? In the previous week, Ardelyx had 14 more articles in the media than Aurora Cannabis. MarketBeat recorded 16 mentions for Ardelyx and 2 mentions for Aurora Cannabis. Ardelyx's average media sentiment score of 0.57 beat Aurora Cannabis' score of 0.50 indicating that Ardelyx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ardelyx 4 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Aurora Cannabis 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate ARDX or ACB? Ardelyx currently has a consensus price target of $9.93, suggesting a potential upside of 96.41%. Given Ardelyx's higher possible upside, equities analysts clearly believe Ardelyx is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ardelyx 0 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.00Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 Which has more volatility & risk, ARDX or ACB? Ardelyx has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.84, indicating that its stock price is 84% more volatile than the S&P 500. Do insiders & institutionals believe in ARDX or ACB? 58.9% of Ardelyx shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 5.9% of Ardelyx shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is ARDX or ACB more profitable? Aurora Cannabis has a net margin of 0.42% compared to Ardelyx's net margin of -28.82%. Aurora Cannabis' return on equity of 0.59% beat Ardelyx's return on equity.Company Net Margins Return on Equity Return on Assets Ardelyx-28.82% -46.60% -21.49% Aurora Cannabis 0.42%0.59%0.42% Which has stronger earnings & valuation, ARDX or ACB? Aurora Cannabis has higher revenue and earnings than Ardelyx. Ardelyx is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArdelyx$124.46M9.62-$66.07M-$0.30-16.85Aurora Cannabis$200.35M1.61-$48.62M$0.05117.82 SummaryArdelyx and Aurora Cannabis tied by winning 9 of the 18 factors compared between the two stocks. Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$323.13M$1.19B$5.80B$8.94BDividend YieldN/AN/A4.78%3.85%P/E Ratio117.8237.7226.4118.84Price / Sales1.615.64450.1476.68Price / Cash25.9110.3144.0437.47Price / Book0.741.927.634.64Net Income-$48.62M-$53.22M$3.18B$245.69M7 Day Performance-6.66%-5.60%-1.82%-2.59%1 Month Performance51.03%-2.89%0.22%-2.30%1 Year Performance73.24%-13.86%17.25%13.71% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.5264 of 5 stars$5.89+0.5%N/A+68.9%$323.13M$200.35M117.821,073Gap UpARDXArdelyx4.3778 of 5 stars$5.79+2.3%$9.42+62.6%-33.1%$1.37B$124.46M-19.3090Earnings ReportAnalyst ForecastNews CoverageINDVIndivior2.6249 of 5 stars$9.83-2.5%$16.00+62.8%-46.0%$1.36B$1.18B-245.691,164Earnings ReportNews CoverageNRIXNurix Therapeutics1.5889 of 5 stars$17.59+0.1%$31.81+80.9%+68.9%$1.33B$54.55M-6.09300VIRVir Biotechnology3.337 of 5 stars$9.65+0.7%$34.83+261.0%-4.2%$1.33B$86.18M-2.46580Insider TradeSNDXSyndax Pharmaceuticals3.6711 of 5 stars$14.92-1.1%$36.20+142.6%-30.1%$1.27BN/A-4.11110ARVNArvinas3.1093 of 5 stars$18.31+3.6%$60.00+227.7%-63.7%$1.26B$78.50M-3.92420Gap UpANIPANI Pharmaceuticals4.4126 of 5 stars$58.92-0.5%$77.71+31.9%+2.3%$1.24B$486.82M-107.13600DAWNDay One Biopharmaceuticals1.993 of 5 stars$12.26+0.4%$35.71+191.3%-17.9%$1.24B$101.95M-11.9060Upcoming EarningsADPTAdaptive Biotechnologies3.6903 of 5 stars$8.33-2.2%$8.30-0.4%+116.4%$1.23B$170.28M-6.22790Analyst ForecastInsider TradeRCUSArcus Biosciences2.7933 of 5 stars$13.05+2.8%$32.67+150.3%-35.2%$1.19B$117M-4.14500Analyst ForecastAnalyst RevisionNews CoverageGap Up Related Companies and Tools Related Companies Ardelyx Competitors Indivior Competitors Nurix Therapeutics Competitors Vir Biotechnology Competitors Syndax Pharmaceuticals Competitors Arvinas Competitors ANI Pharmaceuticals Competitors Day One Biopharmaceuticals Competitors Adaptive Biotechnologies Competitors Arcus Biosciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ACB) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
